IGH gene rearrangement in Acute Lymphoid Leukemia: A study from western region of India

Mahnaz M. Kazi¹ , Pina J. Trivedi² , Dharmesh M. Patel³ , Priya K. Varma⁴ , Archana Patel⁵

1. Cytogenetics Lab, Dept. Cancer Biology, Ahmedabad, India.
2. Cytogenetics Lab, Dept. Cancer Biology, Ahmedabad, India.
3. Cytogenetics Lab, Dept. Cancer Biology, Ahmedabad, India.
4. Cytogenetics Lab, Dept. Cancer Biology, Ahmedabad, India.
5. Cytogenetics Lab, Dept. Cancer Biology, Ahmedabad, India.

Section:Research Paper, Product Type: Journal-Paper
Vol.9 , Issue.6 , pp.30-36, Dec-2022

Online published on Dec 31, 2022

Copyright © Mahnaz M. Kazi, Pina J. Trivedi, Dharmesh M. Patel, Priya K. Varma, Archana Patel . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

140 Views    164 Downloads    33 Downloads

Abstract :
Acute lymphoblastic Leukemia (ALL) is found to be a heterogeneous disorder that coexists with multiple clones. The treatment and outcome of ALL is dependent on risk stratifications of ALL patients that is decided on the basis of prognostic factors such as WBC count, age, immunophenotype and cytogenetic aberrations. There are about 75% of ALL patients that harbors recurring chromosomal aberrations out of which 5% had IGH gene rearrangement. This rearrangement can be detected by Fluorescence in situ Hybridization (FISH). The present work was conducted for studying the prevalence of IGH gene rearrangement and to correlate it with prognostic factors and survival. In the present study, blood, and bone marrow of newly diagnosed 50 ALL patients were included. Molecular cytogenetic method i.e., FISH was used to identify rearrangement in IGH gene present on chromosome 14q32 using IGH break apart probe. The results were statistically analyzed using SPSS software and were considered statistically significant when p value ? 0.05. In the present study, 14 (28%) patients had signal pattern other than 2F. Among 14 patients with abnormal signal pattern, 9 (18%) had rearrangement of IGH gene (OGF), 4 (8%) had gain of IGH gene (FFF/FFFF) and 1 (2%) had loss of IGH gene (F). IGH gene rearrangement and IGH gene abnormality (IGH gene rearrangement, IGH gene gain and IGH gene loss) was found to be significantly associated with B-ALL subtype. Also, IGH gene abnormality was significantly correlated with patients belonging to younger age group and absence of splenomegaly. Additionally, out of total 9 patients with IGH gene rearrangement, 3 (33%) patients died and all of them were of B-ALL subtype. FISH is a powerful tool to analyze cytogenetic abnormalities in patients with ALL. IGH gene rearrangement defines a genetic feature that is frequent among patients with Acute Lymphoblastic Leukemia. Moreover, patients with IGH gene rearrangement and of B-ALL subtype showed poor prognosis.

Key-Words / Index Term :
ALL, IGH gene, Fluorescence in-situ hybridization

References :
[1]. Moorman AV. “The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia,” Blood Reviews Vol. 26, pp. 123–35. 2012.
[2]. Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. “Burkitt’s lymphoma,” The Lancet Vol. 379, pp. 1234–44. 2012
[3]. Freedman, Arnold. "Follicular lymphoma: 2012 update on diagnosis and management." American Journal of Hematology Vol. 87, Issue 10, pp. 988-995. 2012
[4]. González D, van der Burg M, García-Sanz R, Fenton JA, Langerak AW, González M et al. “Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma,” Blood Vol. 110, pp. 3112–21. 2007
[5]. Russell LJ, Enshaei A, Jones L, Erhorn A, Masic D, Bentley H, et al. “IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor Outcome,” Journal of Clinical Oncology Vol. 32, pp. 1453–62. 2014.
[6]. Jeffries SJ, Jones L, Harrison CJ, Russell LJ. “IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia,” Haematologica. Vol. 99, pp. 1334–42. 2014
[7]. Vairy S, Tran TH. “IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly,” Blood Reviews Vol. 44, pp. 100677. 2020.
[8]. Yilmaz, M., Kantarjian, H., Wang, X., Khoury, J.D., Ravandi, F., Jorgensen, J et al. “The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia?negative B?cell acute lymphoblastic leukemia is a strong predictor for survival,” American journal of hematology Vol 95, Issue 2, pp. 144-150. 2020
[9]. Kakaje A, Alhalabi MM, Ghareeb A, Karam B, Mansour B, Zahra B, et al. “Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study,” Scientific Reports Vol. 10, 2020
[10]. Jaime-Pérez JC, García-Arellano G, Herrera-Garza JL, Marfil-Rivera LJ, Gómez- Almaguer D. “Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center,” Hematology, Transfusion and Cell Therapy Vol. 41, pp. 57–61. 2019
[11]. Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, et al. “Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia,” Cancer Management and Research Vol. 10, pp. 625–35, 2018.
[12]. Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante Félix FH, de Oliveira Lopes MV. “Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival,” Revista Brasileira de Hematologia Vol. 37, pp. 223–9. 2015
[13]. Saeedi A, Baghestani A, Khadem Maboudi A, Farhangi H. “Determining the Significant Prognostic Factors for the Recurrence of Pediatric Acute Lymphoblastic Leukemia Using a Competing Risks Approach,” Iranian Journal of Medical Sciences Vol. 45, Issue 4. 2020
[14]. Chen Z, Sun Y, Xie W, Wang SA, Hu S, Li S, et al. “Is hyperdiploidy a favourable cytogenetics in adults with B?lymphoblastic leukemia?” Cancer Medicine Vol. 8, pp. 4093–9, 2019.
[15]. Short NJ, Kantarjian HM, Sasaki K, Ravandi F, Ko H, Cameron Yin C, et al. “Poor outcomes associated with +der(22)t(9;22) and ?9/9p in patients with Philadelphia chromosome?positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor,” American Journal of Hematology Vol. 92, pp. 238–43. 2017
[16]. Von Bergh ARM, van Drunen E, van Wering ER, van Zutven LJCM, Hainmann I, Lönnerholm G, et al. “High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9,” Genes, Chromosomes and Cancer Vol. 45, pp. 731–9. 2006
[17]. Shago, Mary. "Recurrent cytogenetic abnormalities in acute lymphoblastic leukemia." Cancer Cytogenetics; pp 257-278. 2017.
[18]. Motlló C, Ribera J-M, Morgades M, Granada I, Montesinos P, González-Campos J, et al. “Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols,” Cancer Vol. 120. pp. 3958–64. 2014.
[19]. Pui C-H, Robison LL, Look AT. “Acute lymphoblastic leukaemia,” The Lancet Vol. 371, pp. 1030–43. 2008.
[20]. Hutspardol S, Pakakasama S, Kanta K, Nuntakarn L, Anurathapan U, Sirachainan N et al. “Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia,” International Journal of Laboratory Hematology Vol. 35, pp. 406–15. 2012
[21]. Huh J, Mun YC, Yoo ES, Seong CM, Chung WS. “Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements,” Annals of Laboratory Medicine Vol. 35, pp. 128–31, 2015.
[22]. Tarigopula A, Chandrashekar V, Perumal G. “Recurrent genetic abnormalities detected by FISH in adult B ALL and association with hematological parameters,” Cancer Reports Vol. 3, 2020.
[23]. Othman MAK, Grygalewicz B, Pienkowska-Grela B, Rygier J, Enduk A, Rincic M, et al. “A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia,” Oncology Letters Vol. 11, pp 2117–22. 2016